Fresenius Medi receives Investment Bank Analyst Rating Update
- ByInvesting.com-
Investing.com -- With a price increase of 1.30%, Fresenius shares (ETR:FREG) ranked second in the German benchmark DAX index on Thursday. Positive share price impetus was provided...
Investing.com - Fresenius Medical Care ADR (NYSE: FMS) reported first quarter EPS of $0.29, $0.05 better than the analyst estimate of $0.24. Revenue for the quarter came in at...
Although Fresenius Medical Care KGAA ST (DE:FMEG) (NYSE:FMS) is a German company, it has a 38% share of the U.S. dialysis market. The company cares for over 345 000 patients via...
Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:Arconic Corporation ARNC is a provider of aluminum sheet, plate and extrusions, as well as architectural...
OPKO Health, Inc. OPK recently inked an exclusive worldwide agreement with privately held CAMP4 Therapeutics Corporation (CAMP4). The licencing agreement is aimed at developing,...
Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Neutral | Buy | Strong Buy | Sell |
| Technical Indicators | Sell | Strong Sell | Strong Sell | Strong Buy | Buy |
| Summary | Neutral | Sell | Neutral | Strong Buy | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 7.73 | 8.75 | 7.69 | -0.06 | -0.77% | 139.82M | NYSE | |||
| 8.95 | 10.49 | 4.95 | +3.600 | +67.29% | 26.34M | NYSE | |||
| 2.18 | 3.26 | 0.61 | +1.87 | +603.23% | 119.15M | NASDAQ | |||
| 19.07 | 27.33 | 18.70 | -5.16 | -21.30% | 99.38M | NYSE | |||
| 6.04 | 6.91 | 5.50 | +0.6200 | +11.44% | 2.43M | NASDAQ | |||
| 1.33 | 1.38 | 1.26 | -0.020 | -1.48% | 1.99M | NASDAQ | |||
| 58.79 | 59.35 | 58.29 | -0.15 | -0.25% | 1.67M | NYSE | |||
| 11.20 | 11.21 | 11.10 | +0.05 | +0.45% | 253.18K | NASDAQ | |||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 16.41 | 16.60 | 16.31 | -0.29 | -1.74% | 109.00K | NASDAQ | |||
| 0.304 | 0.345 | 0.286 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 122.87 | 124.29 | 122.42 | +0.20 | +0.16% | 20.05M | NASDAQ | |||
| 17.90 | 18.00 | 17.90 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 6.89 | 7.09 | 6.60 | -0.360 | -4.97% | 178.30K | NASDAQ | |||
| 0.7449 | 0.7612 | 0.7101 | +0.0189 | +2.60% | 52.81K | NASDAQ |